Life sciences company Bio-Techne Corporation (NASDAQ: TECH) announced on Wednesday that its board of directors has approved a quarterly dividend of USD0.08 per share for Q3 2024.

This dividend is payable on 22 November 2024 to shareholders of record as of 11 November 2024.

The company said its board will continue to evaluate cash dividends on a quarterly basis.

Bio-Techne provides essential tools and reagents for research and clinical diagnostics, supporting drug discovery and accurate clinical testing. In fiscal 2024, the company reported USD1.2bn in net sales and employs approximately 3,100 people worldwide.